DNA Sequencing Market Estimated To Perceive Distinctive Growth By 2023 :

Pune, India, August 21, 2018 /MRFR Press Release/- Market Research Future published a half-cooked  research report on “Global DNA Sequencing  Market Research Report - Forecast to 2023”  – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

DNA Sequencing refers to the process of determining the precise nucleotides order in a DNA molecule. Owing to its ability to measure real-time nucleotides in addition to a DNA molecule, various types of DNA Sequencing are used in multiple sectors. For instance; for its low-cost, fast analysis methods with precisely high accuracy, Next generation sequencing is extensively used in cancer research.

Simultaneously, type - DNAFET (DNA field-effect transistor) with its ability to use field-effect, exploiting the partial charges of DNA molecules allowing them to behave as a biosensor is opening up new avenues for the charge distribution on complementary DNA strands, converting through the semiconductor transducer.

These advantages of DNA Sequencing procedures are increasing its market size globally. Resultantly, the market for DNA Sequencing is garnering phenomenal traction on the global platform. Market Research Future (MRFR), in its recently published market forecast, asserts that the global DNA Sequencing market will grow exponentially by 2023, registering a decent CAGR throughout the forecast period (2017 – 2023).

Factors such as augmented adoption of precision medicine, evolving complimentary industries along with the increasing applications such as forensic biology, biotechnology, virology and molecular biology drive the market growth for DNA sequencing. Projects such as the human genome and the growing adoption of genetics for livestock and agriculture research are fostering the market growth.

Improving economic conditions enabling access to the quality of life and improved healthcare supports the market growth. However, as the DNA sequencing is still in its nascent stage, there are some challenges to the growth of the market. Factors such as insufficient funds for R&D high cost of development and maintenance, along with the data safety concerns, and ethical considerations among others inhibit the market growth. Nevertheless, private and public funding programs are rapidly increasing the funds for R&D.

DNA Sequencing Market   - Segments

The MRFR analysis is segmented into seven key dynamics for enhanced understanding.

By Products/Types        : Instruments (sequencers, bioreactors, others), Consumables (reagents and chemicals, laboratory wares, other), and Services, among others. 

By Process            : Sequencing, Sample Preparation, and Data Analysis, among others.

By Technologies  : Next Generation DNA Sequencing, and Chain Terminator DNA Sequencing, among others.

By Applications   : Precision Medicine, Diagnostics, Drug Discovery, Agriculture & Livestock Research, and Molecular & Evolutionary Biology, among others.

By Techniques     : Pyro-Sequencing, Ion Semiconductor Sequencing, Synthesis Sequencing (SBS), Chain Termination Sequencing, Ligation Sequencing, Single Molecule Real Time Sequencing (SMRT), and Nano Pore Sequencing among others.

By End-Users       : Hospitals & Clinics, Forensics, Pharmaceutical & Biotechnology Industry, and Genomics & Livestock’s Academics & Research Institutes, among others.

By Regions           :  North America, Europe, APAC, and the Rest-of-the-World.

Access Report @ https://www.marketresearchfuture.com/upcoming-reports/dna-sequencing-market-5774

DNA Sequencing Market   - Regional Analysis

Globally North America market dominates the DNA Sequencing market with the largest share owing to the presence of global players like Thermo Scientific, and Perkin Elmer, among others, and encouraging research and development activities transpired in healthcare. Additional factors such as increased uptake of advanced technologies and high healthcare expenditures are substantiating the market growth.

Owing to the rising demands for DNA Sequencing procedures, the North America market is expected to create a larger revenue pocket in the global market by 2023. The US, backed by the high expenditure on healthcare coupled with the increasing demand for DNA Sequencing, accounts for the major contributor to the market growth.

Whereas Europe accounts for the second-largest market for DNA Sequencing, globally, attributing to the recent advancements in the technology coupled with the augmenting uptake of the technology in the region.  Additionally, the presence of a large medical devices industry and rising healthcare expenditure facilitates the regional market growth. Also, factors such as government support and funding from public & private sectors for research & development are expected to fuel the market growth in the region over the forecasted period.

The Asia-Pacific market is emerging as the rapidly growing market for DNA Sequencing due to the major contributions from South Korea, Japan, India, and China. Backed by the rising demand for these procedures and increasing adoption of the techniques in the procedures, APAC market is expected to register a phenomenal CAGR during the forecast period.

Global DNA Sequencing Market   - Competitive Landscape

The rapidly growing market for DNA Sequencing is fiercely competitive and fragmented with many well-established as well as small & new entrants forming the competitive edge. Innovation, new technology launch and Brand reinforcement remain the popular trends for the key players in the market. The growth statistics of the Nerve market presage the probable heights the market can reach further.

Key Players:

The fervent players leading the global floating power plant market include Roche Holdings AG, Perkin Elmer, Genia Corporation, Siemens AG, Agilent Technologies Inc., Koninklijke Philips N.V., Oxford Nanopore Technologies, Illumina, Pacific Biosciences, Johnson & Johnson, Deep Genomics, Inc., Life Technologies, Hamilton Thorne Biosciences, Eppendorf, Tecan, Myriad Genetics, Thermo Scientific, General Electric Company, Siemens Healthineers GmbH, Beckman Coulter, and Bayer Corporation.

Industry/Innovations/Related News:

August 01, 2018 – Researchers at the National Institutes of Health (NIH – US) published their study of sequencing the fetal DNA that can circulate in a pregnant woman’s blood holds promise for modern genomic medicine. In an article published in the New England Journal of Medicine, the researchers mention that the fetal DNA sequencing can improve the accuracy of prenatal screening tests for genetic conditions and can also lead to the diagnosis of maternal conditions that may have otherwise gone undetected.